DR. JAMES L ROBOTHAM, M.D.
Anesthesiologist Assistant in Seattle, WA

License number
Washington MD60092367
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
4800 M/S W - 9824, Seattle, WA 98105
Phone
(585) 275-5982
(585) 756-0169 (Fax)
(206) 987-5811
(206) 987-3935 (Fax)

Personal information

See more information about JAMES L ROBOTHAM at radaris.com
Name
Address
Phone
James L Robotham, age 24
1304 NE 42Nd St #201, Seattle, WA 98105
James L Robotham, age 77
914 Highland Dr, Seattle, WA 98102
(206) 420-2703
James L Robotham, age 24
914 E Highland Dr #914, Seattle, WA 98102
(206) 420-2703
James Robotham
Seattle, WA
(206) 420-2703

Professional information

James L Robotham Photo 1

Dr. James L Robotham, Seattle WA - MD (Doctor of Medicine)

Specialties:
Pediatric Critical Care Medicine
Address:
SEATTLE CHILDRENS HOSPITAL
4800 Sand Point Way NE, Seattle 98105
(206) 987-2000 (Phone)
4800 Sand Point Way NE, Seattle 98105
(585) 275-5982 (Phone), (585) 756-0169 (Fax)
Certifications:
Anesthesiology, 1987, Pediatric Critical Care Medicine, 1987, Pediatrics, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Boston University School of Medicine
Graduated: 1970
Boston City Hospital
Johns Hopkins Hospital
The Hospital Sick Children


James Lawrence Robotham Photo 2

James Lawrence Robotham, Rochester NY

Specialties:
Pediatrics, Anesthesiology, Geriatric Medicine
Work:
University of Rochester
601 Elmwood Ave, Rochester, NY 14642 Seattle Children's Hospital
4800 Sand Point Way NE, Seattle, WA 98105
Education:
Boston University(1970)


James Robotham Photo 3

Mitochondria-Targeted Antioxidant Prodrugs And Methods Of Use

US Patent:
8470861, Jun 25, 2013
Filed:
Jan 27, 2010
Appl. No.:
12/694337
Inventors:
Marion W. Anders - Pittsford NY, US
James L. Robotham - Seattle WA, US
Shey-Shing Sheu - Pittsford NY, US
Paul Spencer Brookes - Rochester NY, US
Jalil Shojaie - Rochester NY, US
Leif Olson - Riverside RI, US
Richard L. Parton - Webster NY, US
Assignee:
University of Rochester - Rochester NY
International Classification:
A01N 43/50, A01N 43/32, A01N 43/26, A01N 43/16, A01N 31/14, A61K 31/415, A61K 31/385, A61K 31/35, A61K 31/075, A61K 31/08, C07D 339/00, C07D 339/02, C07D 341/00, C07D 409/00, C07D 239/00, C07D 239/02
US Classification:
514385, 514436, 514440, 514456, 514720, 514722, 549 20, 549 35, 544242
Abstract:
The present invention is a mitochondria-targeted antioxidant prodrug useful for the prevention or treatment of diseases or conditions associated with mitochondrial dysfunction resulting from changes in the mitochondrial redox environment. Antioxidant prodrugs of the invention are produced by modifying an antioxidant to a fatty acid so that the resulting prodrug is targeted to and activated by an enzyme of mitochondrial fatty acid beta-oxidation.